Egg Freezing (Oocyte cryopreservation)
RMA of New York is offering
egg freezing, also known as
oocyte cryopreservation, for patients
- Who anticipate having children after the age of 35
- Who are about to go under medical therapies (i.e. radiation
treatment or chemo therapy) and are putting their reproductive
abilities at risk, or
- Who have a family history of endometriosis, premature ovarian
failure, or early menopause.
Egg Freezing may be the right solution in order to
preserve future fertility. The process by which a woman's unfertilized
eggs are extracted from her uterus and are frozen at a very low
temperature. When the woman becomes ready to attempt pregnancy, a
fertility specialist team will slowly thaw her eggs and they will
attempt to fertilize it through In Vitro
Fertilization.
RMA of New York announced a
breakthrough in a multi-site study sponsored by Extend Fertility whereby
it successfully achieved 3 out of 4 pregnancies- a 75%
success rate (Press Release in IN THE NEWS section below).
To inquire about RMA of New York's
oocyte cryopreservation
services, please ask for the oocyte cryopreservation
coordinator at 212-756-5777 or email
info@rmany.com.
In the News
RMA of New York Participates in HOPE Study for Egg
Freezing Patients
RMA of New York is participating in EMD Serono's Human Oocyte
Preservation Experience (HOPE) Registry, an observational study undertaken
to evaluate the safety and efficacy of oocyte cryopreservation techniques.
The HOPE Registry aims to track the outcome of egg freezing cycles from
participating cycles around the country and to validate the efficacy of the
different techniques used to freeze and thaw eggs. Results of safety and
efficacy of egg freezing techniques along with pregnancy outcomes resultant
from the thawing of cryopreserved eggs will be published for public access
upon completion of the study.
Stated Dr. Alan Copperman in a press release: "We need to validate the
safety and efficacy of egg freezing for it to become a more widely available
option for women who for a variety of reasons would like to preserve their
fertility. The HOPE Registry is an exciting vehicle that will assist us in
the evidence-gathering process and will facilitate the furthering of the
science and the acceptance of egg freezing as an effective clinical
practice."
If you would like to know more about egg freezing and the HOPE Study, please contact us at
info@rmany.com.
Marie Claire Magazine Writer Writes About Her Egg Freezing Experience at
RMA of New York and appears with Dr. Tanmoy Mukherjee on Fox Channel's
Mike and Juliet Show
Marie Claire writer and RMA of New York Patient Sarah Elizabeth Richards
talks about her personal experience in freezing her eggs. Click
here to read the article. Click
here to watch the Mike and Juliet Show featuring her and Dr. Mukherjee's
interview.
WCBS Health Watch: Egg Freezing
March 19, 2008- WCBS Reporter Dr. Holly Phillips interviews
Dr. Alan Copperman and Extend Fertility/RMA of New York patient
Lucia Vazquez about the benefits of egg freezing. Click
here to watch the news clip.
Wall Street Journal Article: Why Some Single Women
Choose to Freeze Their Eggs
February 14, 2008; Page D1
Link to Article
Extend Fertility and Reproductive Medicine
Associates of New York Report Encouraging New Egg Freezing Results
Three out of four study participants achieve pregnancy with donated
frozen eggs; results provide additional support for egg freezing as an
option for fertile women
BOSTON and NEW YORK, November 15, 2005 - Extend FertilityTM
and Reproductive Medicine Associates of New York (RMA of NY) today
announced initial results in the ongoing Extend Fertility-sponsored
multi-site study designed to further the science and efficacy of
egg freezing or "egg freezing." The study is designed
to validate the published results and work dealing with the Extend
Fertility method of egg freezing - particularly related to a fertile
women population. In addition to sponsoring the study, Extend Fertility
is also supplying the clinics with exclusive access to training,
protocols and the egg freezing culture media. As part of the overall
study,
RMA of NY and Extend Fertility are
announcing initial results in this unique collaboration.
- The RMA team has achieved three out of four pregnancies
(75 percent pregnancy success rate) using frozen eggs
from fertile egg donors.
- This represents a 26 percent implantation success
rate, i.e. approximately one out of every four embryos
implanted.
- A total of 79 eggs from four donors were frozen. 68 eggs
survived the freezing and thawing process (86.1 percent
survival) and 61 of the remaining eggs successfully
fertilized (89.7 percent fertilization).
"While egg freezing is still considered investigational, these
pregnancies and success rates bring us one step closer to changing the
perception of egg freezing from that of an "on the edge" technology to a
practical and mainstream procedure for women that want to preserve their
ability to have a future family," said
Dr. Alan Copperman, Director of Reproductive Endocrinology at Mount
Sinai Medical Center in New York. "To date, these are some of the most
encouraging success rates on record and we are confident that this kind
of success can be replicated at other
Extend sites. It is also important to note that these results show that
this treatment can be particularly successful for fertile women." The
study participants achieved pregnancy following the retrieval of donor
eggs from a fertile woman, and the eggs' cryopreservation, thawing and
fertilization. Prior to beginning work with the human oocytes (human
eggs), the RMA of New York team
conducted extensive studies on mouse oocytes to perfect their technique.
"We are now confident in our ability to work with the medium and
cryopreservation procedure to achieve continued success. We are ready to
begin offering this investigational service to a wider range of women,
including those looking to preserve their fertility for the future,"
continued Dr Copperman.
"This is truly a groundbreaking development for reproductive technology.
In the past, women who wanted to get pregnant later in life were faced
with egg quality issues. Now they have the option of extending their
fertility by preserving their eggs when they are of the best quality,"
said Christy Jones, founder and CEO, Extend Fertility. "At Extend
Fertility, we are committed to the development of egg freezing and are
confident that we will continue to generate strong pregnancy success
rates at
RMA of NY and other Extend Fertility
partner centers across the country." The ongoing study will be conducted
at up to eight Extend Fertility-affiliated centers throughout the U.S.,
under standard Institutional Review Board (IRB) oversight. In all, about
40 participants are expected to participate. Extend Fertility is
uniquely positioned to sponsor a study of this kind given the company's
focus on developing relationships with some of the leading fertility
centers and specialists in the country. This network of thought-leaders
and experts allows Extend Fertility to ensure a consistent quality of
service while driving research and development around egg
freezing. Complete results and findings will be published
following the completion of the multi-site study in 2006. MediCult and
Biogenics are also supporting the study by donating product and
cryopreservation equipment directly to participating centers.
|